Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, May 14, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Mon, May 13, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Dan Brennan Initiated (BDSX) at Strong Buy and Held Target at $2.8 on, May 13th, 2024
Dan Brennan of TD Cowen, Initiated "Biodesix, Inc." (BDSX) at Strong Buy and Held Target at $2.8 on, May 13th, 2024.
Dan has made no other calls on BDSX in the last 4 months.
There is 1 other peer that has a rating on BDSX. Out of the 1 peers that are also analyzing BDSX, 0 agree with Dan's Rating of Hold.
This is the rating of the analyst that currently disagrees with Dan
- Kyle Mikson of "Canaccord Genuity" Reiterated at Strong Buy and Held Target at $3.5 on, Monday, March 4th, 2024
